VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,283,142 | -59.2% | 243,665 | +6.9% | 0.00% | -50.0% |
Q2 2023 | $5,592,422 | +8.2% | 227,983 | +2.6% | 0.00% | 0.0% |
Q1 2023 | $5,170,641 | -8.1% | 222,202 | -0.1% | 0.00% | 0.0% |
Q4 2022 | $5,627,400 | +33.6% | 222,339 | +1.8% | 0.00% | 0.0% |
Q3 2022 | $4,212,000 | -22.8% | 218,438 | +2.0% | 0.00% | 0.0% |
Q2 2022 | $5,457,000 | +283.8% | 214,257 | +287.6% | 0.00% | – |
Q1 2022 | $1,422,000 | -38.2% | 55,275 | +0.6% | 0.00% | -100.0% |
Q4 2021 | $2,301,000 | -2.0% | 54,960 | +1.9% | 0.00% | 0.0% |
Q3 2021 | $2,347,000 | +11.1% | 53,934 | +20.7% | 0.00% | 0.0% |
Q2 2021 | $2,113,000 | +45.7% | 44,680 | +57.8% | 0.00% | 0.0% |
Q1 2021 | $1,450,000 | +49.9% | 28,309 | -21.7% | 0.00% | – |
Q4 2020 | $967,000 | +3.2% | 36,160 | +32.5% | 0.00% | – |
Q3 2020 | $937,000 | -19.5% | 27,285 | -4.1% | 0.00% | -100.0% |
Q2 2020 | $1,164,000 | +2884.6% | 28,445 | +2419.5% | 0.00% | – |
Q1 2020 | $39,000 | +105.3% | 1,129 | -23.8% | 0.00% | – |
Q4 2019 | $19,000 | – | 1,482 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |